Takeda Pharmaceutical Company Limited Interest Expense On Lease Liabilities
Takeda Pharmaceutical Company Limited (TAK) reported Interest Expense On Lease Liabilities of JPY 24.51 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Expense Statement › Interest Expense
ifrs-full:InterestExpenseOnLeaseLiabilities · last filed 2025-06-25
| Period end | Interest Expense On Lease Liabilities 12 month |
|---|---|
| 2025-03-31 | 24.51B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 20.83B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 16.58B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 13.93B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 12.12B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 11.83B JPY 20-F · filed 2022-06-29 |